Биопрепараты: Профилактика, диагностика, лечение (Feb 2018)
The safety of biological preparations. Part 2. Safety issues of biosimilars
- A. A. Soldatov,
- Zh. I. Avdeeva,
- Yu. V. Olefir,
- V. A. Merkulov,
- V. P. Bondarev
Affiliations
- A. A. Soldatov
- Scientific Centre for Expert Evaluation of Medicinal Products
- Zh. I. Avdeeva
- Scientific Centre for Expert Evaluation of Medicinal Products
- Yu. V. Olefir
- Scientific Centre for Expert Evaluation of Medicinal Products
- V. A. Merkulov
- Scientific Centre for Expert Evaluation of Medicinal Products
- V. P. Bondarev
- Scientific Centre for Expert Evaluation of Medicinal Products
- Journal volume & issue
-
Vol. 16,
no. 2
pp. 78 – 89
Abstract
No abstracts available.Keywords
- биоподобные препараты
- биоаналоговые препараты
- препараты «non-innovators»
- «biosimilars»
- экстраполяция результатов
- взаимозаменяемость
- препараты моноклональных антител
- биоаналоговые инсулины
- biosimilars
- «non-innovators» preparations
- extrapolation of the results
- interchangeability
- preparations of monoclonal antibodies
- biosimilar insulins